BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33831432)

  • 1. Cutaneous Squamous Cell Carcinoma Development Is Associated with a Temporal Infiltration of ILC1 and NK Cells with Immune Dysfunctions.
    Luci C; Bihl F; Bourdely P; Khou S; Popa A; Meghraoui-Kheddar A; Vermeulen O; Elaldi R; Poissonnet G; Sudaka A; Bozec A; Bekri S; Cazareth J; Ponzio G; Barbry P; Rezzonico R; Mari B; Braud VM; Anjuère F
    J Invest Dermatol; 2021 Oct; 141(10):2369-2379. PubMed ID: 33831432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoic acid receptor activity is required for the maintenance of type 1 innate lymphoid cells.
    Asahi T; Abe S; Tajika Y; Rodewald HR; Sexl V; Takeshima H; Ikuta K
    Int Immunol; 2023 Mar; 35(3):147-155. PubMed ID: 36480702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets.
    Robinette ML; Fuchs A; Cortez VS; Lee JS; Wang Y; Durum SK; Gilfillan S; Colonna M;
    Nat Immunol; 2015 Mar; 16(3):306-17. PubMed ID: 25621825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell RNA sequencing identifies a population of human liver-type ILC1s.
    Krämer B; Nalin AP; Ma F; Eickhoff S; Lutz P; Leonardelli S; Goeser F; Finnemann C; Hack G; Raabe J; ToVinh M; Ahmad S; Hoffmeister C; Kaiser KM; Manekeller S; Branchi V; Bald T; Hölzel M; Hüneburg R; Nischalke HD; Semaan A; Langhans B; Kaczmarek DJ; Benner B; Lordo MR; Kowalski J; Gerhardt A; Timm J; Toma M; Mohr R; Türler A; Charpentier A; van Bremen T; Feldmann G; Sattler A; Kotsch K; Abdallah AT; Strassburg CP; Spengler U; Carson WE; Mundy-Bosse BL; Pellegrini M; O'Sullivan TE; Freud AG; Nattermann J
    Cell Rep; 2023 Jan; 42(1):111937. PubMed ID: 36640314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver type 1 innate lymphoid cells lacking IL-7 receptor are a native killer cell subset fostered by parenchymal niches.
    Asahi T; Abe S; Cui G; Shimba A; Nabekura T; Miyachi H; Kitano S; Ohira K; Dijkstra JM; Miyazaki M; Shibuya A; Ohno H; Ikuta K
    Elife; 2023 Jun; 12():. PubMed ID: 37352115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer cells and type 1 innate lymphoid cells in cancer.
    Lopes N; Vivier E; Narni-Mancinelli E
    Semin Immunol; 2023 Mar; 66():101709. PubMed ID: 36621291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum.
    Rodriguez-Rodriguez N; Clark PA; Gogoi M; Ferreira ACF; Kerscher B; Crisp A; Jolin HE; Murphy JE; Sivasubramaniam M; Pedro L; Walker JA; Heycock MWD; Shields JD; Barlow JL; McKenzie ANJ
    Proc Natl Acad Sci U S A; 2022 Dec; 119(49):e2203454119. PubMed ID: 36442116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain endothelial CXCL12 attracts protective natural killer cells during ischemic stroke.
    Wang S; de Fabritus L; Kumar PA; Werner Y; Ma M; Li D; Siret C; Simic M; Li B; Kerdiles YM; Hou L; Stumm R; van de Pavert SA
    J Neuroinflammation; 2023 Jan; 20(1):8. PubMed ID: 36631780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells.
    Lopes N; Galluso J; Escalière B; Carpentier S; Kerdiles YM; Vivier E
    Cell Rep Med; 2022 Nov; 3(11):100812. PubMed ID: 36384102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay Between Liver Type 1 Innate Lymphoid Cells and NK Cells Drives the Development of Alcoholic Steatohepatitis.
    Cheng C; Zhang Q; Li Y; Jiang J; Xie L; Shen H; Wu D; Zhang H; Zhang H; Wang X; Wu H; Xu J; Gui L; Li B; Ju C; Peng H; Yin S; Xu L
    Cell Mol Gastroenterol Hepatol; 2023; 15(1):261-274. PubMed ID: 36174925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression.
    Vashist N; Trittel S; Ebensen T; Chambers BJ; Guzmán CA; Riese P
    Front Immunol; 2018; 9():505. PubMed ID: 29623077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK Cells and ILC1s in Cancer Biology.
    Sliz A; Yokoyama WM
    Adv Exp Med Biol; 2022; 1365():41-55. PubMed ID: 35567740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ILC1: Development, maturation, and transcriptional regulation.
    Taggenbrock RLRE; van Gisbergen KPJM
    Eur J Immunol; 2023 Feb; 53(2):e2149435. PubMed ID: 36408791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Myeloid Leukemia Alters Group 1 Innate Lymphoid Cell Differentiation from a Common Precursor.
    Lordo MR; Wu KG; Altynova E; Shilo N; Kronen P; Nalin AP; Weigel C; Zhang X; Yu J; Oakes CC; Caligiuri MA; Freud AG; Mundy-Bosse BL
    J Immunol; 2021 Sep; 207(6):1672-1682. PubMed ID: 34417259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic granzyme C-expressing ILC1s contribute to antitumor immunity and neonatal autoimmunity.
    Nixon BG; Chou C; Krishna C; Dadi S; Michel AO; Cornish AE; Kansler ER; Do MH; Wang X; Capistrano KJ; Rudensky AY; Leslie CS; Li MO
    Sci Immunol; 2022 Apr; 7(70):eabi8642. PubMed ID: 35394814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hobit confers tissue-dependent programs to type 1 innate lymphoid cells.
    Yomogida K; Bigley TM; Trsan T; Gilfillan S; Cella M; Yokoyama WM; Egawa T; Colonna M
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34880136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.
    Gao Y; Souza-Fonseca-Guimaraes F; Bald T; Ng SS; Young A; Ngiow SF; Rautela J; Straube J; Waddell N; Blake SJ; Yan J; Bartholin L; Lee JS; Vivier E; Takeda K; Messaoudene M; Zitvogel L; Teng MWL; Belz GT; Engwerda CR; Huntington ND; Nakamura K; Hölzel M; Smyth MJ
    Nat Immunol; 2017 Sep; 18(9):1004-1015. PubMed ID: 28759001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural killer cells suppress human cutaneous squamous cell carcinoma cancer cell survival and tumor growth.
    Adhikary G; Heipertz EL; Preradovic M; Chen X; Xu W; Newland JJ; Kaur N; Vemuri MC; Eckert RL
    Mol Carcinog; 2023 Jun; 62(6):845-854. PubMed ID: 36994661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enrichment of type 1 innate lymphoid cells in the course of human atherosclerotic plaque development suggests contribution to atherogenesis.
    Pertiwi KR; Teunissen MBM; Krebbers G; Willems MCM; Huisman L; Poelen C; van der Wal AC; de Boer OJ
    Front Immunol; 2024; 15():1354617. PubMed ID: 38638438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inositol phosphatase INPP4B sustains ILC1s and intratumoral NK cells through an AKT-driven pathway.
    Peng V; Trsan T; Sudan R; Bhattarai B; Cortez VS; Molgora M; Vacher J; Colonna M
    J Exp Med; 2024 Mar; 221(3):. PubMed ID: 38197946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.